Taken together, the symptoms of SMS and PTLS patients and the phenotypes of mice harboring Rai1 deletions or duplications imply that RAI1 functions in multiple pathways related to development and neurological function in a dosage-dependent manner. Here, RAI1 is linked to Smith-Magenis syndrome.